23 May 2013
Keywords: leukosite, lead, product, may, market, biotechnology, company
Article | 28 May 1998
LeukoSite, a US biotechnology company dedicated to the development ofnovel drugs that block diseases caused by white blood cells, has ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 May 1998
22 May 2013
© 2013 thepharmaletter.com